Original Research
Published on 04 Jul 2024
Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia
in Cardiovascular and Smooth Muscle Pharmacology
- 2,545 views
- 4 citations
Original Research
Published on 04 Jul 2024
in Cardiovascular and Smooth Muscle Pharmacology
Mini Review
Published on 27 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 26 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 25 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 20 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 20 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Correction
Published on 18 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 17 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 14 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 13 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 13 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 12 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 11 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Mini Review
Published on 10 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Review
Published on 05 Jun 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 31 May 2024
in Cardiovascular and Smooth Muscle Pharmacology